MedChunk
Medically reviewed

Ankylosing Spondylitis and Fertility: Risks and Care

Learn how ankylosing spondylitis may affect fertility in women and men, how medicines can influence conception, and how to plan care with the rheumatology team.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 13 min read

Ankylosing spondylitis (AS) does not automatically cause infertility. However, some people with AS may take longer to conceive because inflammation, pain, fatigue, sexual difficulties, or certain medicines can affect reproductive health. Planning with a rheumatologist before trying to conceive helps identify potential concerns and allows treatment to be reviewed without unnecessarily disrupting disease control.

Does ankylosing spondylitis affect fertility?

The relationship between ankylosing spondylitis and fertility is not fully understood. Research suggests that the condition may affect reproductive health in some women and men, but the available evidence does not establish that everyone with AS has an increased risk of infertility.

It is also important to distinguish between difficulty conceiving and pregnancy complications. Fertility refers to the ability to achieve a pregnancy, while pregnancy outcomes concern what happens after conception. A person may have AS and experience no difficulty conceiving, although medication planning and pregnancy care may still be important.

How can ankylosing spondylitis affect fertility in women?

Most research on female fertility in ankylosing spondylitis is limited. A 2024 review published in Frontiers in Immunology describes several possible factors, including changes in ovarian reserve, disease activity, medication exposure, physical limitations, and psychological stress. Some studies have reported lower levels of anti-Müllerian hormone (AMH), a hormone used as one marker of ovarian reserve.

Ovarian reserve refers to the remaining supply of eggs in the ovaries. A lower AMH level does not automatically mean that a woman cannot become pregnant. It is one part of fertility assessment and must be interpreted alongside age, menstrual history, other reproductive factors, and relevant examination findings.

Can pain and fatigue make conception more difficult?

AS can cause back pain, hip discomfort, stiffness, and fatigue. These symptoms may make sexual activity uncomfortable or reduce the frequency of intercourse. Limited movement may also make some sexual positions difficult.

Emotional concerns can contribute as well. Worry about pregnancy, body image, chronic pain, or the possibility of passing a health condition to a child may affect sexual confidence and desire.

These difficulties do not necessarily indicate a problem with the reproductive organs. Addressing pain, fatigue, mobility, and emotional well-being may improve comfort and make it easier for couples to maintain an active sex life while trying to conceive.

Can ankylosing spondylitis affect male fertility?

Male fertility may be affected in some men with ankylosing spondylitis, although the research is still developing. A 2024 review in Current Rheumatology Reports found that some small studies linked higher spondyloarthritis disease activity with poorer sperm quality, including reduced sperm movement. However, the available studies are limited in size, and their findings do not establish that AS causes infertility in every affected man.

Sperm quality includes several features, such as:

  • Sperm concentration: The number of sperm present in a semen sample.
  • Sperm motility: How well sperm move, which is important for reaching and fertilizing an egg.
  • Sperm morphology: The shape and structure of sperm.
  • Sperm vitality: The proportion of living sperm in a sample.

Changes in these measurements do not automatically mean that natural conception is impossible. Semen quality is only one part of fertility, and both partners may contribute to the time it takes to achieve pregnancy.

Does controlling inflammation improve male fertility?

There is some evidence that active inflammation may be associated with poorer semen parameters. Research involving tumor necrosis factor (TNF) inhibitors has generally been reassuring about their effects on male reproductive health. These medicines may also help control inflammation, which is important for overall well-being.

However, the evidence is not extensive enough to guarantee that every medicine has the same effect in every patient. Men planning to father a child should discuss their treatment with their rheumatologist rather than stopping a biologic medicine without advice.

Which ankylosing spondylitis medicines may affect fertility?

Medication is an important part of fertility planning because some drugs may affect sperm production, ovulation, or the safety of a future pregnancy. These effects are not interchangeable. A medicine that may affect sperm count is not necessarily harmful to a woman trying to conceive, and a medicine that does not reduce fertility may still require changes before pregnancy.

Nonsteroidal anti-inflammatory drugs (NSAIDs)

NSAIDs, such as ibuprofen and naproxen, are commonly used to manage pain and inflammation in AS. Their use around the time of conception may be relevant for women trying to become pregnant.

Some research involving women with spondyloarthritis has found an association between NSAID use before conception and a longer time to pregnancy. This does not prove that NSAIDs were the sole cause of the delay, and the findings should not be interpreted as meaning that every woman taking these medicines will experience fertility problems.

The American College of Rheumatology recommends considering discontinuation of NSAIDs before conception when a patient is having difficulty conceiving, provided that disease control will not be compromised. This decision should be made with the treating clinician because uncontrolled inflammation and pain also require appropriate management.

Sulfasalazine

Sulfasalazine is sometimes prescribed for inflammatory arthritis associated with spondyloarthritis. It has a specific effect on male reproductive health: it may reduce sperm count and contribute to temporary difficulty conceiving.

According to the NHS guidance on sulfasalazine and fertility, sperm counts generally improve within two to three months after stopping the medicine. This effect is usually reversible, but treatment should only be changed after discussing the risks and alternatives with a healthcare professional.

For women, the NHS reports no evidence that sulfasalazine reduces fertility. However, the medicine can affect folate levels. Women taking it who plan to become pregnant are advised to discuss high-dose folic acid supplementation with their healthcare professional. The NHS recommends 5 mg daily, particularly during the three months before trying to conceive and the first 12 weeks of pregnancy.

Biologic medicines and other treatments

Biologic medicines, particularly TNF inhibitors, are an important treatment option for some people with AS. Available research has not identified a clear negative effect of TNF inhibitors on male semen quality. The American College of Rheumatology recommends continuing TNF inhibitors in men planning to father a pregnancy. Its reproductive-health guideline also provides medication-specific recommendations for people with rheumatic diseases who are planning pregnancy.

For women who may become pregnant, the safety of a medicine during pregnancy must be assessed separately from its effect on fertility. Some medicines may need to be changed or stopped before conception, while others can be continued. The appropriate approach depends on the individual medicine, disease activity, and pregnancy plans.

Do not stop NSAIDs, sulfasalazine, biologics, or other prescribed medicines independently. A sudden change can allow inflammation to return and may make symptoms more difficult to manage.

How should you plan for pregnancy with ankylosing spondylitis?

Preconception planning gives patients and healthcare professionals time to review treatment, assess disease control, and identify other factors that might affect conception. Ideally, this discussion should happen before actively trying to become pregnant.

Arrange a preconception appointment

Start with a discussion with your rheumatologist. Depending on your circumstances, an obstetrician-gynecologist or fertility specialist may also be involved.

Important topics to discuss include:

  • Your current AS symptoms and how well inflammation is controlled.
  • All prescribed medicines, including NSAIDs, sulfasalazine, biologics, and other treatments.
  • Whether any medicine needs to be changed before conception.
  • How to manage pain and stiffness without unnecessarily affecting fertility.
  • Previous reproductive difficulties, menstrual concerns, sexual health, and other medical conditions.
  • Whether additional fertility testing or specialist assessment is appropriate.

Maintain disease control

Planning a pregnancy does not mean that AS treatment should be stopped. Keeping the disease under control is important for physical function, daily activities, and general health.

Your rheumatologist can help identify an appropriate treatment plan that considers both disease management and reproductive goals. If a medication change is necessary, the team can discuss an alternative and allow time to assess how well it controls symptoms before conception.

Address problems with sexual activity

Persistent pain, hip stiffness, fatigue, or reduced sexual desire should be discussed during routine care. Treatment adjustments, physical therapy, suitable activity modifications, and help with emotional distress may improve comfort and sexual well-being.

Men experiencing erectile difficulties or women experiencing pain during intercourse should also mention these concerns. Sexual difficulties can be part of a fertility problem even when reproductive organs and hormone levels are otherwise normal.

What fertility tests may be needed?

There is no single fertility test that can determine whether AS has affected someone's ability to conceive. Testing depends on age, medical history, symptoms, how long pregnancy has been attempted, and whether either partner has known reproductive concerns.

For women, a fertility assessment may include a review of menstrual cycles, ovulation, reproductive history, and relevant hormonal tests. AMH testing or ultrasound assessment of ovarian reserve may be considered when clinically appropriate. An AMH result alone cannot reliably determine whether natural pregnancy will occur.

For men, a semen analysis may help assess sperm concentration, movement, and shape. It may be particularly useful when conception is taking longer than expected or when sulfasalazine exposure raises concerns about sperm count.

Both partners should be considered during a fertility assessment. The cause of difficulty conceiving may be related to either partner, both partners, or a combination of reproductive and health factors.

When should couples with AS seek fertility advice?

It is reasonable to discuss fertility with a healthcare professional before trying to conceive, especially when treatment changes may be needed. An earlier assessment may also be appropriate if there are known reproductive problems, irregular menstrual cycles, sexual difficulties, or concerns about semen quality.

The American Society for Reproductive Medicine's 2026 guidance recommends an infertility evaluation after 12 months of regular, unprotected intercourse when the female partner is younger than 35. For women aged 35 or older, assessment is recommended after six months. Women older than 40 may benefit from more immediate evaluation. These timelines apply to general fertility care and may be shortened when a known reproductive concern is present.

It is not necessary to wait until these time periods have passed if there is already a reason to investigate fertility. A clinician can determine whether evaluation should begin sooner based on the medical and reproductive history of both partners.

Can people with ankylosing spondylitis use fertility treatment?

Having AS does not automatically prevent someone from receiving fertility treatment. Options such as ovulation-related treatment, intrauterine insemination, or in vitro fertilization may be considered when appropriate for the couple's fertility findings.

People undergoing fertility treatment should coordinate care between their rheumatologist and reproductive specialist. This is especially important when treatment involves hormonal stimulation, changes to anti-inflammatory medicines, or a planned pregnancy.

The aim is to address fertility concerns while maintaining suitable control of AS. Treatment decisions should account for the patient's reproductive goals, disease activity, age, medication history, and the findings of the fertility assessment.

What is the overall outlook for fertility with ankylosing spondylitis?

Many people with ankylosing spondylitis can pursue parenthood. The condition does not automatically lead to infertility, but some aspects of the disease and its treatment may affect the time it takes to conceive.

For women, research is still limited, although ovarian reserve, pain, disease activity, and certain medicines are areas of interest. For men, some studies suggest a relationship between inflammation and sperm quality, while findings about TNF inhibitors have generally been reassuring. Sulfasalazine is a recognized cause of potentially reversible reductions in sperm count.

Early family planning, appropriate disease control, and an individualized medication review can help people make informed reproductive decisions. When conception is difficult, a fertility assessment should consider both partners rather than assuming that AS is the only explanation.

Frequently Asked Questions

Common questions about ankylosing spondylitis, fertility, medicines, and planning a family.

Can a woman with ankylosing spondylitis get pregnant naturally?

Yes. Having ankylosing spondylitis does not automatically prevent natural conception. Although some studies have identified possible changes in ovarian reserve and longer time to pregnancy, the evidence remains limited. Many factors, including age, reproductive health, symptoms, and medications, influence an individual's chances of conceiving.

Does ankylosing spondylitis cause male infertility?

Not necessarily. Some small studies suggest that active inflammation may be associated with changes in sperm movement or quality. However, the evidence does not establish that every man with AS will experience infertility. A semen analysis can help investigate concerns about sperm health.

Should men stop sulfasalazine when trying to have a baby?

Not without medical advice. Sulfasalazine can reduce sperm count in some men, but this effect is generally reversible after stopping treatment. A rheumatologist can discuss whether an alternative medicine or semen analysis is appropriate.

Should people with ankylosing spondylitis stop biologics before trying to conceive?

Not automatically. Available research is generally reassuring about the effects of TNF inhibitors on male fertility. For women planning pregnancy, the safety of each biologic during pregnancy needs an individual review. Medication changes should always be planned with the treating rheumatologist.

Citations

  1. Frontiers in Immunology – Fertility Issues in Women of Childbearing Age With Spondyloarthritis (2024)
  2. Current Rheumatology Reports – Male Fertility in Spondyloarthritis: From Clinical Issues to Cytokines Milieu (2024)
  3. NHS – Pregnancy, Breastfeeding and Fertility While Taking Sulfasalazine
  4. American College of Rheumatology – 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
  5. American Society for Reproductive Medicine – Fertility Evaluation of Infertile Women: A Committee Opinion (2026)
Share this article